Diabetes Flashcards

(49 cards)

1
Q

Diabetes diagnosis

with symptoms

A

fasting > 7
random > 11.1
HbA1c > 48 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pre-diabetes

A

HbA1c 42-47 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T1 diabetes gene assoc?

A

HLA DR3, DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diabetes management

A
  1. Metformin
  2. DPP-4i - sitagliptin
  3. Pioglitazone (ttd)
  4. Sulfonylurea - gliclazide
  5. SGLT-2i - (glifozin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sulfonylureas action

A

enhance endogenous insulin secretion (B-cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

sulfonylureas examples

A

Gliclazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

biguanides action

A
  • increase glucose uptake
  • decrease hepatic gluconeogenesis
  • increase peripheral insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

biguanides example

A

METFORMIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

sulfonylureas side effects

A

weight gain
hypoglycaemia
hyponatraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

biguanides side effects

A

GI upset: nausea, diarrhoea

lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DPP-4 inhibitors example

A

sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DPP-4 inhibitors action

A
  • increase incretin levels
  • prevents peripheral breakdown (longer action)
  • inhibits glucagon secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DPP-4 inhibitors side effects

A

well tolerated

pancreatitis risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

thiazolidinediones action

A

Activate PPARG receptor in adipocytes

adipogenesis & FA uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

thiazolidinediones side effects

A

weight gain
fluid retention
bladder cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

thiazolidinediones example

A

pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SGLT-2 inhibitors

A

selective sodium glucose contransporter 2 inhibitors

inhibits glucose reaborption in kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SGLT-2 inhibitors example

A

-gliflozins

empagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

SGLT-2 inhibitors side effects

A

UTI (bacteria love sugar)

weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

GLP-1 agonists action

A

mimics incretin

inhibits glucagon secretion

21
Q

GLP-1 agonists example

22
Q

GLP-1 agonists side effects

A

N & V

pancreatitis

23
Q

who do I NOT give metformin to

A

GFR <30

increased chance of lactic acidosis

24
Q

if HbA1c still >58

A

add gliptin first, then another

if 3 not effective add a GLP-1 agonist

25
ACE inhibitors in T2D
reno-protective against nephropathy afrocarribean (offer + CCB/thiazide)
26
BP target in T1D, albuminuria, metabolic syndrome
130/80 | 140/90 - otherwise
27
what drug do I avoid when already on thiazide
beta blockers impaired insulin secretion insulin resistance impaired response to hypoglycaemia
28
basal bolus
rapid acting insulin with meals | long acting insulin at bedtime
29
biphasic 30/70 mixed insulin - T2D uncontrolled
30% rapid 70% intermediate increase night dose slowly?
30
acanthosis nigricans
associated w T2 diabetes
31
best investigation for dm
HbA1c glycated Hb reflects exposure over last 6-8wks
32
serum osmolality
2x (Na + K) + Urea + Glucose
33
DKA path?
infection, missed insulin, MI uncontrolled lipolysis FFAs --> ketones
34
DKA features
``` abdominal pain polyuria, dipsia dehydration kussmaul resp acetone breath ```
35
DKA diagnosis
glucose >11 ph <7.3 ketones >3 or ++ bicarb <15
36
DKA mgmt?
0.9% saline 1L over 30 minutes (if sbp <90) when glucose <15mmol/L start 5% dextrose infusion IV insulin 0.1 units/kg/hr K replacement (insulin)
37
HHS path?
hyperosmolar hyperglycaemia state - T2D osmotic diuresis w loss of Na/K - severe dehydration, high glucose - raised serum osmolarity >320 - hyper-viscous blood - clot risk
38
HSS diagnosis
hypovolaemia hyperglycaemia >30mmol/L without sig ketone/acidosis serum osmolarity >320
39
HSS management
IV 0.9% saline - gradually normalise osmolality if need to normalise glucose - insulin LMWH
40
Insulin side effects
weight gain | ...
41
complications of DM
end-stage renal failure
42
autonomic symptoms of hypoglycaemia
``` Sweating Hunger Anxiety Tremor Palpitations ```
43
neuroglycopenic symptoms of hypoglycaemia
``` Confusion Drowsiness Seizures Coma Personality change ```
44
causes of hypoglycaemia
``` exogenous insulin/gliclazide insulinoma liver failure addisons alcohol ```
45
investigating DKA in ED
VBG
46
Diabetes insipidus
- nephrogenic = no response to ADH | - cranial = pit dysfunction, no ADH (treat w desmopressin)
47
Water deprivation test
low, high = cranial | low, low = nephrogenic
48
T1D antibodies
Anti-islet | Anti-GAD
49
diabetes screening for complications
``` Macro - Pulses - BP - Cardiac auscultation Micro - Fundoscopy - ACR + U+Es - Sensory testing plus foot inspection ```